FIVE PRIME THERAPEUTICS, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for FIVE PRIME THERAPEUTICS, INC. (FPRX), sourced directly from SEC EDGAR and updated as new filings are accepted.
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are FPRX insiders buying or selling?
FIVE PRIME THERAPEUTICS, INC. insiders reported no open-market purchases or sales in the last 12 months. Since October 2019, Trabud has recorded 14 Form 4 filings for FPRX: 11 buys ($18.4M) and 3 sells ($151.3M).
Source: SEC EDGAR Form 4
Key Statistics (October 2019 – Nov 13, 2020)
Insider sentiment
Net sellingNet insider flow of $132.9M in net selling since October 2019.
Recent FPRX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 13, 2020 | BVF PARTNERS L P/IL | Other | Sale | 7.4M | $20.19 | $149.2M | SEC ↗ |
| Nov 13, 2020 | William R Ringo | Director | Sale | 79.0K | $22.50 | $1.8M | SEC ↗ |
| Nov 6, 2020 | BVF PARTNERS L P/IL | 10% Owner | Purchase | 446.6K | $4.89 | $2.2M | SEC ↗ |
| Oct 8, 2020 | BVF PARTNERS L P/IL | 10% Owner | Purchase | 345.2K | $5.04 | $1.7M | SEC ↗ |
| Sep 24, 2020 | BVF PARTNERS L P/IL | 10% Owner | Purchase | 32 | $3.80 | $121.56 | SEC ↗ |
| May 19, 2020 | BVF PARTNERS L P/IL | 10% Owner | Purchase | 293.6K | $4.10 | $1.2M | SEC ↗ |
| Dec 26, 2019 | BVF PARTNERS L P/IL | 10% Owner | Purchase | 515.0K | $4.05 | $2.1M | SEC ↗ |
| Dec 11, 2019 | BVF PARTNERS L P/IL | 10% Owner | Purchase | 135.0K | $4.02 | $542.4K | SEC ↗ |
| Dec 4, 2019 | Franklin M Berger | Director | Sale | 80.0K | $3.97 | $317.4K | SEC ↗ |
| Nov 26, 2019 | BVF PARTNERS L P/IL | 10% Owner | Purchase | 1.1M | $3.40 | $3.8M | SEC ↗ |
| Nov 8, 2019 | BVF PARTNERS L P/IL | 10% Owner | Purchase | 968.1K | $4.00 | $3.9M | SEC ↗ |
| Oct 31, 2019 | BVF PARTNERS L P/IL | 10% Owner | Purchase | 29.3K | $3.88 | $113.8K | SEC ↗ |
| Oct 25, 2019 | BVF PARTNERS L P/IL | 10% Owner | Purchase | 169.4K | $3.75 | $634.3K | SEC ↗ |
| Oct 8, 2019 | BVF PARTNERS L P/IL | 10% Owner | Purchase | 601.5K | $3.74 | $2.3M | SEC ↗ |
Showing the 14 most recent of 14 Form 4 filings for FIVE PRIME THERAPEUTICS, INC..
Most active FPRX insiders
- BVF PARTNERS L P/IL12 filings
- Franklin M Berger1 filing
- William R Ringo1 filing
Ask anything about FPRX insider activity
Use Trabud's AI agent to query FIVE PRIME THERAPEUTICS, INC.'s Form 4 history in plain English — "Show me FPRX CEO purchases this year" or compare it against any other ticker.
Open the AI agentFPRX insider trading FAQ
Are FIVE PRIME THERAPEUTICS, INC. insiders buying or selling?
FIVE PRIME THERAPEUTICS, INC. insiders reported no open-market purchases or sales in the last 12 months. Since October 2019, Trabud has recorded 14 Form 4 filings for FPRX: 11 buys ($18.4M) and 3 sells ($151.3M). Over the full record that is net selling of $132.9M.
How many insiders trade FPRX stock?
3 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for FIVE PRIME THERAPEUTICS, INC.. The most recent filing was accepted on Nov 13, 2020.
Where does Trabud get FPRX insider trading data?
All FPRX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.